RNA-targeted therapeutics in cardiovascular disease: the time is now

KA Krychtiuk, DJ Rader… - European Heart Journal …, 2023 - academic.oup.com
Ribonucleic acid (RNA)-targeted therapeutics, including antisense oligonucleotide
technologies as well as small interfering RNAs (siRNAs), represent a new class of …
被引用次数：6 相关文章

RNA-targeted therapeutics in cardiovascular disease: the time is now

KA Krychtiuk, DJ Rader… - European heart journal …, 2022 - pubmed.ncbi.nlm.nih.gov
Ribonucleic acid (RNA)-targeted therapeutics, including antisense oligonucleotide
technologies as well as small interfering RNAs (siRNAs), represent a new class of …

RNA-targeted therapeutics in cardiovascular disease: the time is now

KA Krychtiuk, DJ Rader… - European Heart Journal …, 2023 - academic.oup.com
Ribonucleic acid (RNA)-targeted therapeutics, including antisense oligonucleotide
technologies as well as small interfering RNAs (siRNAs), represent a new class of …

RNA-targeted therapeutics in cardiovascular disease: the time is now

KA Krychtiuk, DJ Rader… - European Heart Journal …, 2023 - search.proquest.com
Ribonucleic acid (RNA)-targeted therapeutics, including antisense oligonucleotide
technologies as well as small interfering RNAs (siRNAs), represent a new class of …